Hemicellulase

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Hemicellulase
DrugBank Accession Number
DB15820
Background

Not Available

Type
Biotech
Groups
Experimental
Synonyms
  • Albazyme-10A
  • Endo-1,4-beta-xylanase A
  • Gammanase
  • Gemmicellulase
  • Hemicellulase
  • Hemicellulase (aspergillus niger)
  • Hemicellulase reg II
  • Pulpzyme
  • Xylavomarin

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
FLATON ENTERIK DRAJE, 30 ADETHemicellulase (50 mg) + Ox bile extract (25 mg) + Pancrelipase amylase (3150 FIP) + Pancrelipase lipase (1050 FIP) + Pancrelipase protease (210 FIP) + Simethicone (50 mg)Tablet, coatedOralBİLİM İLAÇ SAN. VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
FLATON ENTERIK DRAJE, 60 ADETHemicellulase (50 mg) + Ox bile extract (25 mg) + Pancrelipase amylase (3150 FIP) + Pancrelipase lipase (1050 FIP) + Pancrelipase protease (210 FIP) + Simethicone (50 mg)Tablet, coatedOralBİLİM İLAÇ SAN. VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
StozymeHemicellulase (10.42 1/1001) + Dimethicone (5.21 1/1001) + Ox bile extract (5.21 1/1001) + Pancrelipase (36.46 1/1001)TabletOralChunwoo Pharmaceutical Co., Ltd.2019-10-19Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
StozymeHemicellulase (10.42 1/1001) + Dimethicone (5.21 1/1001) + Ox bile extract (5.21 1/1001) + Pancrelipase (36.46 1/1001)TabletOralChunwoo Pharmaceutical Co., Ltd.2019-10-19Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
S2MZZ5DR1O
CAS number
9025-56-3

References

General References
Not Available
RxNav
26514
Wikipedia
Cellulase

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Tablet, coatedOral
TabletOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on September 09, 2020 19:24 / Updated on September 11, 2020 12:08